PMA device
Verify Evaluation System for Interstim Therapy for Urinary Control and Bowel Control
Medtronic Neuromodulation · Implanted Electrical Device Intended For Treatment Of Fecal Incontinence (QON, Class III) · First FDA decision Jun 26, 2015, newest Jun 26, 2015Fecal incontinence and constipation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
141
Naming "Verify Evaluation"
MAUDE reports
0
Brand "Verify Evaluation", since 2015
PubMed studies
0
Mentioning "Verify Evaluation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Verify Evaluation System for Interstim Therapy for Urinary Control and Bowel Control
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P080025-S083 · Decided Jun 26, 2015 · 179 days after receipt · Normal 180 Day Track
Device type: Implanted electrical device intended for treatment of fecal incontinence (QON) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Sacral Nerve Stimulation for the Treatment of Urinary and Fecal IncontinenceLocal determinationIn effectL39543Palmetto GBAUpdated Sep 12, 2023
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of WoundsNational determinationOn the books270.1Updated Nov 4, 2026
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Electrical Aversion Therapy for Treatment of AlcoholismNational determinationOn the books130.4Updated Jun 10, 2020
- Biofeedback Therapy for the Treatment of Urinary IncontinenceNational determinationOn the books30.1.1Updated Sep 24, 2015
- Home Health-Surface Electrical Stimulation in the Treatment of DysphagiaLocal determinationIn effectL34565Palmetto GBAUpdated Nov 21, 2023
- Surface Electrical Stimulation in the Treatment of DysphagiaLocal determinationIn effectL34578Palmetto GBAUpdated Aug 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Verify Evaluation", any status and sponsor, newest update first.
- NaviCam Patency Capsule to Verify Gastrointestinal PatencyNot yet recruiting
AnX Robotica Corp.Not on our public-company list
NCT07649720 · 25 participants (planned) · Start Feb 15, 2027 · Primary completion Sep 30, 2027
Device: NaviCam Patency Capsule · For: Intestinal Stricture; Crohn Disease; NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy and 1 more
Sites: Downers Grove, Illinois
140 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Verify Evaluation", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QON
10 reports: 3 malfunction, 7 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Enhanced Verify Evaluation Handset (CFN HH90130FA)Open, Classified
Z-1704-2025 · Started Apr 3, 2025 · Posted by FDA Apr 30, 2025
Reason given: Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms...
Cause as FDA categorized it: Device Design · Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
4 more recall records with a free account
Published research
The most relevant PubMed records for "Verify Evaluation"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QON.
- Axonics Sacral Neuromodulation SystemBoston Scientific Corporation · PMA 2026
- InterStim Therapy System, Verify Evaluation SystemMedtronic Neuromodulation · PMA 2025
- InterStim® Sacral Nerve Stimulation Therapy System / Bowel ControlMedtronic Neuromodulation · PMA 2018
- Test Stimulation Lead Bulk Accessory,test Stimulation Lead KitMedtronic Neuromodulation · PMA 2013
- Model 3058 Interstim II NeurostimulatorMedtronic Neuromodulation · PMA 2012
- Interstim SystemMedtronic Neuromodulation · PMA 2011
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.